Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 62.50 GBp
Change Today 0.00 / 0.00%
Volume 0.0
As of 11:35 AM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

rex bionics plc (RXB) Snapshot

62.50 GBp
Previous Close
62.50 GBp
Day High
62.50 GBp
Day Low
62.50 GBp
52 Week High
05/8/14 - 182.50 GBp
52 Week Low
04/22/15 - 62.50 GBp
Market Cap
Average Volume 10 Days
-0.63 GBp
Shares Outstanding
Dividend Yield
Current Stock Chart for REX BIONICS PLC (RXB)

Related News

No related news articles were found.

rex bionics plc (RXB) Related Businessweek News

No Related Businessweek News Found

rex bionics plc (RXB) Details

Rex Bionics Plc develops and manufactures hands-free robotic exoskeletons for use by wheelchair users in New Zealand. The company offers REX Rehab for use in rehabilitation centers and hospitals; and REX Personal for individual’s specific medical and physical requirements to perform tasks and functions. It sells its products in North America, Europe, and the Asia Pacific. The company was formerly known as Union MedTech plc and changed its name to Rex Bionics Plc in March 2012. Rex Bionics Plc was incorporated in 2007 and is based in North Shore City, New Zealand.

Founded in 2007

rex bionics plc (RXB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

rex bionics plc (RXB) Key Developments

Rex Bionics Plc and Deltason Medical Ltd. Establish Partnership to Commercialise the REX Robot in Hong Kong

Rex Bionics plc and Deltason Medical Ltd. announced that they have signed a distribution agreement in which Deltason will exclusively represent REX in Hong Kong, both in neuro-rehabilitation clinics and in the personal use market. Deltason will launch REX at the Hong Kong International Medical Devices and Supplies Fair (May 18-20, 2015).

Rex Bionics plc Announces Unaudited Consolidated Earnings Results for the Year Ended November 30, 2014

Rex Bionics Plc announced unaudited consolidated earnings results for the year ended November 30, 2014. For the period, the company reported revenue of GBP 215,000 against GBP 176,000 for the same period a year ago. Operating loss was GBP 3,694,000 compared to GBP 1,217,000 a year ago. Loss from ordinary activities before taxation was GBP 3,698,000 compared to GBP 1,246,000 a year ago. Loss for the period was GBP 3,564,000 compared to GBP 1,246,000 a year ago. Basic and diluted loss per share from continuous and total operations was 42.0 pence compared to 46.8 pence a year ago. Net cash outflow from operating activities was GBP 3,692,000 compared to GBP 980,000 a year ago. The company reported property, plant equipment at a cost of GBP 281,000 against GBP 26,000 for the same period a year ago.

Rex Bionics Plc to Report Fiscal Year 2014 Results on Feb 25, 2015

Rex Bionics Plc announced that they will report fiscal year 2014 results on Feb 25, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RXB:LN 62.50 GBp 0.00

RXB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CYBERDYNE Inc ¥3,120 JPY -130.00
Ekso Bionics Holdings Inc $1.64 USD +0.04
Parker-Hannifin Corp $122.22 USD +0.59
ReWalk Robotics Ltd $10.76 USD +0.05
View Industry Companies

Industry Analysis


Industry Average

Valuation RXB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 41.0x
Price/Book 0.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 40.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REX BIONICS PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at